These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34144696)

  • 21. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
    Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
    Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.
    Hiotis SP; Rahbari NN; Villanueva GA; Klegar E; Luan W; Wang Q; Yee HT
    BMC Gastroenterol; 2012 Jun; 12():64. PubMed ID: 22681852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K
    Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.
    Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Tsuge M; Chayama K
    Hepatology; 2011 Apr; 53(4):1237-45. PubMed ID: 21480328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.
    Qin S; Wang J; Zhou C; Xu Y; Zhang Y; Wang X; Wang S
    Medicine (Baltimore); 2019 Sep; 98(38):e17275. PubMed ID: 31568008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection.
    Huo TI; Wu JC; Lai CR; Lu CL; Sheng WY; Lee SD
    J Hepatol; 1996 Oct; 25(4):439-44. PubMed ID: 8912142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.
    Yu MC; Tong MJ; Coursaget P; Ross RK; Govindarajan S; Henderson BE
    J Natl Cancer Inst; 1990 Jun; 82(12):1038-41. PubMed ID: 2161463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan.
    Abdul Mujeeb S; Jamal Q; Khanani R; Iqbal N; Kaher S
    Trop Doct; 1997 Jan; 27(1):45-6. PubMed ID: 9030022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fulminant Labrea hepatitis--the role of hepatitis A (HAV), B (HBV), C (HCV), and D (HDV) infection. (Preliminary report).
    da Fonseca JC; Ferreira LC; Brasil LM; Castilho Mda C; Moss R; Barone M
    Rev Inst Med Trop Sao Paulo; 1992; 34(6):609-12. PubMed ID: 1342132
    [No Abstract]   [Full Text] [Related]  

  • 40. Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk.
    Huang YT; Yang HI; Liu J; Lee MH; Freeman JR; Chen CJ
    Epidemiology; 2016 Jan; 27(1):14-20. PubMed ID: 26443934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.